LP-10 (Liposomal Tacrolimus)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluating LP-10 in Subjects With OLPNCT06233591Lipella Pharmaceuticals, Inc.Phase 2Unknown2025-06-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.